newsfilter
← Latest News
GlobeNewswire·

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

  • Ascendis Pharma A/S (NASDAQ: ASND) will report second quarter 2026 financial results & provide a business update on Thursday, August 13, 2026, before the open of U.S. financial markets.
  • The company will host a conference call & live webcast at 8:00 a.m. Eastern Time on August 13, 2026, to discuss the financial results.
  • Participants can access the live webcast via the provided link, register in advance, or visit the Investors & News section of the Ascendis Pharma website.
  • A replay of the webcast will be available on the company website for 30 days following the event.
  • Ascendis Pharma is a global biopharmaceutical company headquartered in Copenhagen, Denmark, that utilizes its TransCon technology platform to develop therapies for unmet medical needs.
  • The press release includes forward-looking statements regarding future operations, plans, & the application of TransCon technology, warning that actual results may differ materially due to risks such as regulatory delays, clinical trial outcomes, manufacturing issues, & market acceptance challenges.
  • Investor & media contact information for Chad Fugere & Melinda Baker is provided with phone numbers +1 (650) 519-7494 & +1 (650) 709-8875.